MANGALAM DRUGS & ORGANICS LTD. - 532637 - Outcome Of Board Meeting Held On Monday, July 5, 2021
Outcome of Board Meeting held on Monday, July 5, 202105-07-2021
05-07-2021
Mangalam Drugs & Organics Ltd - 532637 - Closure of Trading Window
In terms of provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company''s Code for prohibition of Insider Trading, the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (including their immediate relatives) from Thursday, July 1, 2021 till the expiry of forty-eight (48) hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021.30-06-2021
Mangalam Drugs & Organics Ltd - 532637 - Update On Setting-Up Of New Intermediate Manufacturing Facility At Unit 1 Located In Vapi, Gujarat.
Update on Setting-up of new intermediate manufacturing facility at Unit 1 located in Vapi, Gujarat.18-06-2021
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the year ended March 31, 2021.11-06-2021
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Intimation in pursuance of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding receipt of Resignation from Statutory Auditors of the Company.09-06-2021
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2021 issued by Mr. Ankit Sethi - Practicing Company Secretary & Secretarial Auditor of the Company.04-06-2021
Mangalam Drugs & Organics Ltd - 532637 - Audited Financial Results (Standalone) For The Quarter And Year Ended March 31, 2021.
Audited Financial Results (Standalone) for the quarter and year ended March 31, 2021.20-05-2021
Mangalam Drugs & Organics Ltd - 532637 - Outcome Of The Board Meeting Held On Thursday, May 20, 2021
Outcome of the Board Meeting held on Thursday, May 20, 202120-05-2021
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Board Meeting To Be Held On Thursday, May 20, 2021.
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2021 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter / year ended March 31, 2021.11-05-2021
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Certificate Under Regulation 40(9) / 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2021
In terms of Regulation 40(9) / 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time please find attached herewith the Certificate for the half year ended March 31, 2021 issued by CS Priya Shah - Practicing Company Secretary.26-04-2021